Literature DB >> 25859599

[Glial fibrillary acidic protein: the component of intermediate filaments in the vertebrate brain astrocytes].

E G Sukhorukova, D É Kruzhevskiĭ, O S Alekseeva.   

Abstract

Glial fibrillary acidic protein (GFAP) refers to the type III intermediate filament proteins and is the essential component of the cytoskeleton in astrocytes of all vertebrates. This review presents current data on the molecular organization of GFAP in a comparative aspect. The results of most relevant studies using immunocytochemical labeling of the protein are summarized. The data on the changes in expression of GFAP in Alexander disease caused by the primary pathology of astrocytes are presented.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25859599

Source DB:  PubMed          Journal:  Zh Evol Biokhim Fiziol        ISSN: 0044-4529


  4 in total

1.  A Rare Malignant Peripheral Nerve Sheath Tumor of the Maxilla Mimicking a Periapical Lesion.

Authors:  José Alcides Arruda; Pamella Álvares; Luciano Silva; Alexandrino Pereira Dos Santos Neto; Cleomar Donizeth Rodrigues; Antônio Caubi; Marcia Silveira; Sandra Sayão; Ana Paula Sobral
Journal:  Case Rep Dent       Date:  2016-11-23

2.  Expression of CCDC85C, a causative protein for hydrocephalus, and intermediate filament proteins during lateral ventricle development in rats.

Authors:  Md Mehedi Hasan; Shizuka Konishi; Miyuu Tanaka; Takeshi Izawa; Jyoji Yamate; Mitsuru Kuwamura
Journal:  Exp Anim       Date:  2021-12-23

3.  Ultrasound Targeted Microbubble Destruction Promotes the Therapeutic Effect of HUMSC Transplantation on Glaucoma-Caused Optic Nerve Injury in Rabbits.

Authors:  Tianhui Zhu; Xiaosheng Huang; Shiming Peng; Ye Ye; Jun Zhao
Journal:  Transl Vis Sci Technol       Date:  2022-05-02       Impact factor: 3.283

4.  Alternative splicing landscape of the neural transcriptome in a cytoplasmic-predominant Pten expression murine model of autism-like Behavior.

Authors:  Stetson Thacker; Marilyn Sefyi; Charis Eng
Journal:  Transl Psychiatry       Date:  2020-11-06       Impact factor: 6.222

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.